These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 22643868)

  • 21. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
    Quattrocelli M; Thorrez L; Sampaolesi M
    Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genomic stability of induced pluripotent stem cells.
    Chen Z; Zhao T; Xu Y
    Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
    Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.
    Poetsch MS; Strano A; Guan K
    Stem Cells; 2022 Jun; 40(6):546-555. PubMed ID: 35291013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
    Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
    Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
    BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular reprogramming: a small molecule perspective.
    Nie B; Wang H; Laurent T; Ding S
    Curr Opin Cell Biol; 2012 Dec; 24(6):784-92. PubMed ID: 22959962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
    Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
    JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin.
    Yan X; Xu N; Meng C; Wang B; Yuan J; Wang C; Li Y
    Am J Transl Res; 2016; 8(2):419-32. PubMed ID: 27158336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
    Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
    Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
    Yoshihara M; Hayashizaki Y; Murakawa Y
    Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.